Aditxt, Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aditxt, Inc. stock issued during period, value, conversion of units for the quarter ending 2022-09-30 was $20.00K, a 99.65% decline year-over-year.
- Aditxt, Inc. stock issued during period, value, conversion of units for the quarter ending 2021-09-30 was $5.75M.
- Aditxt, Inc. stock issued during period, value, conversion of units for the quarter ending 2021-03-31 was $1.32M.
- Aditxt, Inc. stock issued during period, value, conversion of units for fiscal 2023 was $2.69M.
- Aditxt, Inc. stock issued during period, value, conversion of units for fiscal 2022 was -$20.00K, a 100.35% decline from fiscal 2021.
- Aditxt, Inc. stock issued during period, value, conversion of units for fiscal 2021 was $5.75M.
- Aditxt, Inc. stock issued during period, value, conversion of units for fiscal 2019 was $533.31K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2023-12-31 | $2.69M 10-K · filed 2025-03-31 | |
| 2022-12-31 | -$20.00K 10-K · filed 2023-04-17 | |
| 2022-09-30 | $20.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $5.75M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $5.75M 10-Q · filed 2021-11-15 | |
| 2021-03-31 | $1.32M 10-Q · filed 2022-11-14 | |
| 2019-12-31 | $533.31K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |